Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04568395 · ClinicalTrials.gov registry record · NA
Acute Effects of TCIG vs ECIG in PLWH
A NA study of Inflammation and Smoking, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
- 2
- Study locations
NCT04568395: Completed NA study of Inflammation and Smoking, sponsored by University of California, Los Angeles.
NCT04568395 is a NA study of Inflammation and Smoking that has completed, run by University of California, Los Angeles. The registered enrollment target is 37 participants, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (87% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04568395, a NA study of Inflammation and Smoking, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
- 2
- Study locations
Study Summary
Randomized controlled trial of acute use of electronic cigarette or tobacco cigarette on parameters of ventricular repolarization and inflammation/oxidative stress.
Primary Outcome
interval indicative of ventricular repolarization measured on ECG
Conditions Studied
Interventions
- OTHER TCIG
- OTHER ECIG
- OTHER sham control
Study Locations (2)
California
- UCLA - Los Angeles
- UCaliforniaLA - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2023-05-08 |
| Phase | NA |
What the finished NCT04568395 record still lists
NCT04568395 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 37 participants, a relatively small participant target, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (87% lower).
The record links to 9 conditions, with Inflammation appearing as the primary indexed condition, and to 3 interventions - of which TCIG is the first listed.
NCT04568395 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04568395 about?
NCT04568395 is a clinical study titled "Acute Effects of TCIG vs ECIG in PLWH". Randomized controlled trial of acute use of electronic cigarette or tobacco cigarette on parameters of ventricular repolarization and inflammation/oxidative stress.
What is the current status of trial NCT04568395?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2020-10-01. Estimated completion is 2023-05-08.
What conditions does trial NCT04568395 study?
This clinical trial studies the following conditions: Inflammation, Smoking, Tobacco Smoking, Oxidative Stress, Vaping.
What interventions are being tested in trial NCT04568395?
The interventions under investigation include: TCIG (OTHER), ECIG (OTHER), sham control (OTHER).
Who is sponsoring clinical trial NCT04568395?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04568395 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inflammation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04568395's enrollment target sits among peer trials
37 89th of 132 higher than 43 of 132 other Inflammation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Inflammation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet on Cellular Zinc
RECRUITING · NA
-
Evaluating Whether Hyperbaric Oxygen Therapy Can Improve VO₂-Max and Reduce Inflammation Markers in Healthy Adults Ages 30-60.
RECRUITING · NA
-
Impact of NMES and HPRO on Recovery After SAH- Pilot Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI